Project Grant R01CA312358
Award Date 8/3/26
Completion Date 7/31/31
Dollars Obligated $693K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Baltimore, MD 21205, USA
Similar Awards
- The National Cancer Institute awarded Trustees of Dartmouth College $100,228 on February 14, 2027, under the Cancer Research Manpower program (CFDA 93.398) to develop absolute quantitative oxygen-enhanced MRI (AQOE-MRI), a method combining an FDA-approved oxychip electron paramagnetic resonance spin probe with relaxometry measurements to generate absolute PO2 values for mapping tumor hypoxia and guiding radiation therapy dose escalation. The project runs through August 16, 2028, and is performed...
- The National Institutes of Health National Cancer Institute awarded The Johns Hopkins University $477,674 on June 1, 2026, under the Cancer Detection and Diagnosis Research program (CFDA 93.394, assistance type Project Grant R01CA287368) to conduct molecular imaging research on the immune-suppressive tumor microenvironment in prostate cancer. The research applies molecular and functional imaging methods to understand how hypoxia, metabolism, prostate fibroblasts, and the extracellular matrix...
- Federal Project Grant Award Summary Award Details: The National Cancer Institute (NCI) awarded O2M Technologies LLC a $1,164,814 Project Grant on September 19, 2025, under the Cancer Detection and Diagnosis Research Program (CFDA 93.394) for research extending through August 31, 2027. The award supports the development of advanced imaging methods in pulse electron paramagnetic resonance (EPR) to enable precise partial oxygen pressure (pO2) measurements for cancer diagnosis and treatment...
- Federal Grant Award Summary The National Cancer Institute (NCI) awarded Johns Hopkins University a $144,193 Project Grant under the Cancer Detection and Diagnosis Research program (CFDA 93.394) effective September 4, 2025 through August 31, 2030. This award provides protected salary support for Dr. Preethi Korangath to serve as a Laboratory Research Specialist in Dr. Robert Ivkov's laboratory, where she will facilitate the completion of Research Project Grants (R01) by leveraging her expertise...
- The National Cancer Institute awarded The Johns Hopkins University $249,000 on January 1, 2026, under the Cancer Detection and Diagnosis Research program (CFDA 93.394) to develop large-scale artificial intelligence using radiomics, deep learning, and physics-based generative modeling to improve clinical outcomes in nuclear medicine. The award funds three specific aims: construction of a large database of clinical positron emission tomography/computed tomography images with physician-annotated...
- The National Institutes of Health National Cancer Institute awarded Cold Spring Harbor Laboratory $793,679 on August 6, 2026, under the Cancer Biology Research program (CFDA 93.396) to develop whole-body redox maps for metastatic cancer therapy. The project uses protein degradation-based sensing to visualize oxidative stress in vivo across animal models of prostate cancer. The work generates two complementary, immune-competent mouse models—OXIGEM and ROXYCAP—that reveal cellular redox states...
- The National Cancer Institute awarded The Johns Hopkins University $399,829 on July 1, 2026, under the Cancer Detection and Diagnosis Research program (CFDA 93.394) to identify imaging biomarkers using multiplexed digital pathology data to predict clinical outcomes in triple-negative breast cancer. The project applies spatially resolved, high-throughput single-cell computational analysis to characterize tumor microenvironment immune architecture in breast cancer specimens, with the goal of...
- The National Cancer Institute awarded The Trustees of Columbia University in the City of New York $594,297 on June 18, 2026, to develop elasticity imaging methodologies for breast cancer detection and treatment monitoring under the Cancer Detection and Diagnosis Research program (CFDA 93.394). The award funds two noninvasive theranostic approaches: Harmonic Motion Imaging (HMI) for monitoring locally advanced malignant tumors during neo-adjuvant chemotherapy, and HMI-guided focused ultrasound...
- The National Cancer Institute awarded The Johns Hopkins University $399,829 on July 1, 2026, under the Cancer Detection and Diagnosis Research program (CFDA 93.394) to develop Vascular Expansion Microscopy (VascExM), a method for high-resolution optical imaging of brain vasculature at endothelial cell scale on standard, diffraction-limited microscopes. The work addresses the need for sub-micron vascular imaging in preclinical and clinical neuropathology samples. The recipient will develop...
- The National Cancer Institute awarded The Washington University $645,414 on June 18, 2026, under the Cancer Detection and Diagnosis Research program (CFDA 93.394) to develop integrin-targeted positron emission tomography imaging and therapeutics for predicting and treating radiation-induced pulmonary fibrosis in lung cancer patients. The project uses mouse models of radiation-induced pulmonary fibrosis to test two complementary approaches: non-invasive αvβ6 PET imaging to detect early...